Aesica has been granted a Certificate of Suitability for Paroxetine Hydrochloride
Aesica Pharmaceuticals Ltd. has been recently granted a Certificate of Suitability by the European Directorate for the Quality of Medicines (EDQM) for its Paroxetine Hydrochloride anhydrous and hemihydrate. The certificate numbers are:
- Paroxetine Hydrochloride Anhydrous: RO-CEP-2006-096-REV00
- Paroxetine Hydrochloride Hemihydrate: RO-CEP-2006-081-REV00
Further details can be obtained by contacting our regulatory department:
Ashleigh Gordon
Regulatory Affairs Officer
E-mail: ashleigh.gordon@aesica-pharma.com
